AC
MRVI icon

AXQ Capital’s Maravai LifeSciences MRVI Stock Holding History

AXQ Capital’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$128K Sell
20,548
-10,326
-33% -$44.6K 0.01% 783
2026
Q1 		$87.4K Sell
30,874
-13,120
-30% -$44.5K 0.01% 886
2025
Q4 		$143K Buy
43,994
+17,135
+64% +$57.7K 0.03% 619
2025
Q3 		$77.1K Buy
+26,859
New +$68.6K 0.03% 528
2025
Q2 		– Sell
-35,391
Closed -$78.2K – 700
2025
Q1 		$78.2K Buy
+35,391
New +$140K 0.03% 454
2024
Q3 		– Sell
-37,982
Closed -$272K – 537
2024
Q2 		$272K Sell
37,982
-13,093
-26% -$113K 0.06% 373
2024
Q1 		$443K Sell
51,075
-3,525
-6% -$23.8K 0.11% 331
2023
Q4 		$358K Buy
+54,600
New +$353K 0.1% 342

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.91B AUM 14.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
1WCM
12 West Capital Management New York $535M AUM 25.99% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OAM
Ophir Asset Management Sydney, Australia $1.22B AUM 100.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

AXQ Capital's MRVI Position: Q2 2026 in Review

AXQ Capital reduced its Maravai LifeSciences (MRVI) stake by 33% in Q2 2026, selling an estimated $44.6K and leaving 20,548 shares worth $128K. The position accounts for 0.01% of the portfolio, ranked #783.

AXQ Capital first reported a position in MRVI in Q4 2023 and has held it in 8 quarters since. The position peaked at $443K in Q1 2024. 178 funds tracked by Wall St. Rank hold MRVI as of Q2 2026.

  • AXQ Capital held 20,548 shares of Maravai LifeSciences worth $128K as of Q2 2026.
  • AXQ Capital sold 10,326 Maravai LifeSciences shares in Q2 2026, an estimated $44.6K.
  • Maravai LifeSciences made up 0.01% of AXQ Capital's portfolio in Q2 2026, its #783 holding.
  • AXQ Capital first reported a position in Maravai LifeSciences in Q4 2023 and has held it in 8 quarters since.
  • AXQ Capital's Maravai LifeSciences position peaked at $443K in Q1 2024.
  • 178 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.